Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Kamaz reported for the 3 months of 2025 by RAS

4/30/25 KMAZ

Transneft reported for 3 months of 2025 by RAS

4/30/25 TRNFP

TGK-2 reported for 3 months of 2025 by RAS

4/30/25 TGKB

FGC-Rosseti reported for 3 months of 2025 by RAS

4/30/25 FEES

“Nornickel reports for 3 months of 2025 by RAS

4/30/25 GMKN

Gazprom reports for 2024 by IFRS

4/30/25 GAZP

Aeroflot reported for 3 months of 2025 by RAS

4/30/25 AFLT

SFI reported for 3 months of 2025 by RAS

4/30/25 SFIN

Varioganneftegaz reported for 2024 by RAS

4/30/25 VJGZ

Varioganneftegaz reported for 2024 by IFRS

4/30/25 VJGZ